Risk Factor

How Type 2 Diabetes Affects Your Cognitive Health

Type 2 diabetes increases dementia risk by up to 65%. Here is why — and what optimal diabetes management means for your brain.

8 min read
Medical note: Keel is a personal wellness tracker, not a medical device or diagnostic tool. The information on this page is for educational purposes only. If you have concerns about your cognitive health, please consult a qualified healthcare professional.

What the research says

Type 2 diabetes is associated with a 50-65% increased risk of dementia, with evidence linking it to both Alzheimer's disease and vascular dementia. The association is so strong that Alzheimer's disease has been proposed (though controversially) as 'type 3 diabetes' — reflecting the overlap between insulin resistance pathways and Alzheimer's pathology.

The mechanisms include vascular effects (diabetes damages blood vessels throughout the body, including cerebral blood vessels), direct effects of insulin resistance on brain glucose metabolism, advanced glycation end products (AGEs) that damage neuronal structures, inflammation, and oxidative stress. Poor glycemic control — measured by HbA1c — is more predictive of cognitive outcomes than diabetes diagnosis alone.

Research consistently shows that people with poorly controlled diabetes have worse cognitive outcomes than those with well-controlled blood sugar, suggesting that glycemic management is not just metabolically important but neurologically important.

Which cognitive domains are most affected

Type 2 diabetes most consistently affects processing speed, executive function, and verbal memory. The vascular effects of diabetes (cerebral small vessel disease) drive processing speed and executive function decline; direct neuronal effects influence memory.

Hypoglycemic episodes — low blood sugar events — can also cause acute cognitive impairment and, if recurrent and severe, may contribute to lasting cognitive effects. Glycemic stability (avoiding both high blood sugar and severe lows) appears important for cognitive protection.

What you can do

Optimizing glycemic control — reducing HbA1c toward target — is the most direct cognitive protective intervention for people with type 2 diabetes. Aerobic exercise is particularly valuable because it improves insulin sensitivity, supports glucose metabolism in the brain, and has independent cognitive benefits through BDNF release and cardiovascular improvements.

Dietary patterns supporting blood sugar control — reduced refined carbohydrates, Mediterranean or MIND diet patterns — have both metabolic and cognitive benefits. Managing comorbid cardiovascular risk factors (blood pressure, cholesterol) is also critical, as their effects compound those of diabetes.

Why tracking your baseline matters

For people with type 2 diabetes, daily cognitive tracking provides an objective record that complements periodic HbA1c measurements. Changes in processing speed and executive function can reflect changes in cerebrovascular health or glycemic control that are not yet visible in other monitoring parameters.

Correlating cognitive performance data with blood sugar management changes — starting a new medication, improving dietary adherence, beginning an exercise program — provides personal evidence of whether interventions are producing cognitive benefits.

Frequently asked questions

Does controlling blood sugar protect my brain?

Yes, the evidence is consistent that better glycemic control (lower HbA1c) is associated with better cognitive outcomes in type 2 diabetes. This does not guarantee prevention of cognitive decline, given the multiple mechanisms involved, but optimizing blood sugar management is among the highest-yield cognitive health interventions for someone with diabetes.

Can type 2 diabetes cause dementia?

Type 2 diabetes significantly increases dementia risk but does not directly cause dementia in most people. The increased risk is probabilistic. Well-managed diabetes with good glycemic control, cardiovascular risk management, and healthy lifestyle reduces this risk substantially compared to poorly managed diabetes.

Are there diabetes medications that protect the brain?

Research is ongoing into whether certain diabetes medications (notably GLP-1 receptor agonists like semaglutide) have neuroprotective effects beyond glycemic control. Early data are promising but not yet definitive. Any medication decisions should be made with a healthcare provider who can consider the full clinical context.

Start tracking your cognitive baseline

Four minutes a day. Five short tests. One trend line that builds over weeks and months so you can see where you stand — and separate a bad day from a real change.

Free to start. No account required. Not a diagnostic tool.

Keel is a personal wellness tracker. It is not a medical device, diagnostic tool, or substitute for professional medical advice. If you have concerns about your cognitive health, consult a qualified healthcare professional. The information on this page is for educational purposes and should not be used to self-diagnose or self-treat any condition.